次世代定序資訊學市場－全球產業規模、佔有率、趨勢、競爭格局、機會、預測：按產品/服務、應用、最終用戶、地區和競爭格局分類，2021-2031年

全球次世代定序(NGS) 資訊學市場預計將從 2025 年的 57.3 億美元成長到 2031 年的 197.4 億美元，複合年成長率為 22.89%。

NGS資訊學涵蓋了處理和解讀定序技術產生的大量資料所需的關鍵專用軟體、分析儀器和管理解決方案，為個人化醫療、診斷和研究等領域提供支援。這一市場擴張的主要驅動力是精準醫療需求的不斷成長、基因組學領域的持續進步以及需要進行複雜評估的基因組數據激增。全球基因組與健康聯盟在2026年4月發布的2025年度報告中強調了這個不斷擴展的數據環境，指出其國際合作夥伴管理超過300萬個基因組。

阻礙市場成長的主要障礙之一是各種NGS資訊系統之間持續缺乏標準化和相容性，導致協作資料交換困難。除了對敏感資訊的隱私和安全擔憂之外，這種碎片化也嚴重阻礙了全球基因組學領域的順利運作和廣泛整合。

市場促進因素

基因組資訊規模和複雜性的快速成長是全球次世代定序(NGS) 資訊學市場的核心驅動力。隨著定序成本的降低和處理能力的提升，醫療專業人員和科學家正在產生前所未有的大量原始數據，包括轉錄組、EXOME子組和全基因組序列。高效儲存、組織和評估這些海量資料集需要能夠處理Petabyte級資料的先進資訊學平台。這種資訊過載正在加速對專注於註釋、變異檢測、比對和品質保證的自動化應用程式的需求。 Illumina 在 2025 年 11 月的部落格報導《領導視角：Illumina 引領基因組人工智慧產業》中強調了這一持續的數據爆炸性成長，該文章指出，目前該領域每年產生的基因組數據超過 400 億 GB。

此外，人工智慧 (AI)、雲端運算技術和先進數據分析與新一代定序 (NGS) 資訊學的日益整合也促進了市場的復甦。這些創新技術在從複雜的基因組數據中獲取有價值的生物學見解、提高診斷準確性以及自動化繁瑣的分析流程方面發揮著至關重要的作用。雲端平台為資料處理和儲存提供了一個靈活的框架，促進了合作研究；而人工智慧和機器學習模型則透過檢測大規模基因組資料集中的細微趨勢來改善疾病預測和變異評估。例如，Stock Titan 於 2026 年 4 月 14 日發布的一份報告詳細介紹了 Illumina 與生物醫學數據驅動發現中心 (Center for Data-Driven Discovery in Biomedicine) 的合作，利用雲端運算、人工智慧和軟體系統分析 10 萬名兒童的全基因組，這體現了人工智慧驅動基因組學應用範圍的不斷擴大。總而言之，全球基因組學領域正在穩步發展。作為證據，美國國家人類基因組研究所 (NHGRI) 於 2024 年 3 月發布的《2025 財政年度國會預算說明》指出，預計 2025 財政年度將撥款 6.637 億美元用於基因組學研究。

市場挑戰

不同平台和工具之間持續缺乏相容性和標準化是全球次世代定序(NGS) 資訊學市場擴張的主要障礙。這種碎片化的局面使得製藥公司、診斷實驗室和研究中心難以有效協作和共用資訊。缺乏統一的資料結構迫使每個機構進行繁瑣的客製化整合，導致營運成本增加和開發週期延長。最終，這種低效率會減緩基因組研究成果轉化為可操作醫療方案的進程。

此外，人們對高度敏感的基因組數據的安全性和隱私性的普遍擔憂加劇了這些挑戰。這些擔憂導致了嚴格的法規結構的實施和資訊共用的意願降低，阻礙了數據的順暢流動和利用。機構仍不願採用缺乏健全隱私保護的NGS資訊學平台，導致市場接受度有限。皮斯托亞聯盟的「未來實驗室2025」調查凸顯了這個問題，調查顯示，49%的實驗室認為資料本體和標準是阻礙資訊實現「可尋找、可存取、可互通和可重複使用」（FAIR）的主要障礙。這最終成為阻礙NGS資訊學領域創新和新興服務發展的障礙。

市場趨勢

整合全面的多組體學資料的能力正在改變次世代定序(NGS) 資訊學的全球格局，它有助於人們超越孤立的資料類別，深入理解生物網路。這一趨勢的重點在於整合代謝體學、蛋白質組學、轉錄組學和基因組學訊息，以建立患者的全面分子圖譜，這是治療方法分類和疾病理解的關鍵步驟。因此，NGS 資訊學系統正在不斷發展，以處理和評估這些龐大而多樣的資料集，從而為更深入的生物學發現鋪平道路。為了凸顯整合體學分析的戰略價值，Illumina 於 2025 年 6 月 23 日發布新聞稿，宣布計劃以 3.5 億美元收購 SomaLogic，新聞稿標題為「Illumina 收購 SomaLogic 以加速蛋白質組學業務並推進其多體學戰略」。此次收購旨在整合基於適配體的工具，並增強多組體學物標記的偵測能力。

另一個重要趨勢是次世代定序(NGS) 資訊學與臨床診斷的融合日益加深，其應用也主要從科學研究轉向常規病患照護。這種轉變要求醫院和檢查室部署先進的分析程序和軟體，以實現個人化治療策略、病原體鑑定和遺傳疾病篩檢。向臨床環境的過渡需要直覺可靠的資訊系統，能夠提供準確快速的數據，從而指導關鍵的醫療決策。 Illumina 公司於 2025 年 12 月 11 日發布的新聞稿《Illumina 與 MyOme 達成合作協議，包括戰略投資以支持 MyOme 臨床試驗，預計每年為美國醫療保健系統節省 2000 億美元》強調了這種融合帶來的巨大醫療和經濟效益，指出廣泛採用臨床全基因測序並結合

目錄

第1章 產品概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：全球次世代定序（NGS）資訊學市場展望

• 市場規模及預測
  • 按金額
• 市佔率及預測
  • 按產品/服務分類（儲存和計算工具、商業數據分析、數據解釋和報告工具、次世代定序(NGS) 實驗室資訊管理系統 (LIMS)）
  • 依應用領域（藥物發現、基因篩檢、疾病診斷等）
  • 依最終用戶（醫院/診斷中心、製藥/生技公司、學術/研究機構）分類
  • 按地區
  • 按公司（2025 年）
• 市場地圖

第6章：北美次世代定序（NGS）資訊學市場展望

• 市場規模及預測
• 市佔率及預測
• 北美洲：國別分析
  • 美國
  • 加拿大
  • 墨西哥

第7章：歐洲次世代定序（NGS）資訊學市場展望

• 市場規模及預測
• 市佔率及預測
• 歐洲：國別分析
  • 德國
  • 法國
  • 英國
  • 義大利
  • 西班牙

第8章：亞太地區次世代定序（NGS）資訊學市場展望

• 市場規模及預測
• 市佔率及預測
• 亞太地區：國別分析
  • 中國
  • 印度
  • 日本
  • 韓國
  • 澳洲

第9章：中東與非洲次世代定序（NGS）資訊學市場展望

• 市場規模及預測
• 市佔率及預測
• 中東與非洲：國別分析
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 南非

第10章：南美洲次世代定序（NGS）資訊學市場展望

• 市場規模及預測
• 市佔率及預測
• 南美洲：國別分析
  • 巴西
  • 哥倫比亞
  • 阿根廷

第11章 市場動態

• 促進因素
• 任務

第12章 市場趨勢與發展

• 併購
• 產品發布
• 近期趨勢

第13章：全球次世代定序（NGS）資訊學市場：SWOT分析

第14章：波特五力分析

• 產業競爭
• 新進入者的潛力
• 供應商的議價能力
• 顧客權力
• 替代品的威脅

第15章 競爭格局

• Abbott Laboratories
• F. Hoffmann-La Roche Ltd.
• PerkinElmer, Inc.
• SOPHiA GENETICS SA
• Precigen, Inc.
• QIAGEN NV
• Illumina, Inc.
• Agilent Technologies, Inc.
• Eagle Genomics Limited
• BGI Genomics Co., Ltd.

第16章 策略建議

第17章：關於研究公司及免責聲明

The Global Next Generation Sequencing (NGS) Informatics Market is expected to expand from USD 5.73 billion in 2025 to USD 19.74 billion by 2031, reflecting a compound annual growth rate of 22.89%. NGS informatics involves dedicated software, analytical instruments, and management solutions essential for handling and deciphering the vast data produced by sequencing technologies, supporting areas like personalized medicine, diagnostics, and research. This market expansion is mainly fueled by the rising need for precision therapies, ongoing progress in genomics, and the surge in genomic data requiring sophisticated evaluation. Emphasizing this growing data environment, the Global Alliance for Genomics and Health noted in its 2025 Annual Report released in April 2026 that its international partners managed more than three million genomes.

A major obstacle hindering the market's growth is the ongoing deficit in standardization and compatibility across various NGS informatics systems, making collaborative data exchange difficult. Along with worries regarding the privacy and security of sensitive information, this fragmentation creates a substantial barrier to achieving smooth operations and broad integration throughout the worldwide genomics landscape.

Market Driver

The rapid expansion in the size and complexity of genomic information is a central driver for the Global Next Generation Sequencing (NGS) Informatics Market. With falling sequencing expenses and rising processing capacities, medical professionals and scientists are producing record volumes of raw data, encompassing transcriptome, exome, and whole-genome sequences. Efficiently storing, organizing, and evaluating these massive datasets necessitates advanced informatics platforms capable of processing petabytes of data. This flood of information accelerates the need for automated applications dedicated to annotation, variant calling, alignment, and quality assurance. Highlighting this ongoing data boom, a November 2025 blog post by Illumina titled 'Leadership Perspectives: Illumina leads the industry in genomic AI' reported that the sector currently produces more than 40 billion gigabytes of genomic data annually.

The market is additionally stimulated by the growing incorporation of artificial intelligence (AI), cloud technologies, and sophisticated data analytics into NGS informatics. These innovations play a crucial role in deriving valuable biological conclusions from intricate genomic data, increasing diagnostic precision, and automating tedious analytical procedures. Cloud platforms provide adaptable frameworks for processing and storing data, fostering shared research initiatives, while AI and machine learning models improve disease forecasting and variant assessment by detecting nuanced trends in extensive genomic groups. Illustrating the rising scope of AI-assisted genomics, an April 14, 2026, Stock Titan report detailed an Illumina partnership with the Center for Data-Driven Discovery in Biomedicine that utilized cloud, AI, and software systems to analyze 100,000 pediatric whole genomes. More broadly, the global genomics field is steadily expanding, as evidenced by the National Human Genome Research Institute's March 2024 'Fiscal Year 2025 Congressional Justification,' which outlined an estimated budget of $663.7 million for genomics research in the 2025 fiscal year.

Market Challenge

The sustained absence of compatibility and standardization across various platforms and tools remains a major hurdle restricting the expansion of the Global Next Generation Sequencing (NGS) Informatics Market. This disconnected landscape makes it difficult for pharmaceutical firms, diagnostic labs, and research centers to collaborate and share information effectively. Because uniform data structures are missing, organizations must perform labor-intensive custom integrations that drive up operational expenses and extend developmental timelines. Ultimately, this inefficiency delays the process of turning genomic discoveries into practical medical treatments.

Furthermore, prevalent anxieties regarding the security and privacy of highly sensitive genomic data exacerbate these challenges. Such worries prompt rigorous regulatory frameworks and hesitant information sharing, which obstruct the fluid movement and application of data. Facilities remain reluctant to implement NGS informatics platforms that do not feature stringent privacy safeguards, thereby restricting broader market adoption. Highlighting this issue, the 2025 Lab of the Future survey by the Pistoia Alliance revealed that 49% of labs viewed data ontologies and standards as a primary obstacle keeping information from becoming Findable, Accessible, Interoperable, and Reusable (FAIR), a barrier that ultimately suppresses innovation and the growth of emerging services within the NGS informatics field.

Market Trends

The capacity to integrate holistic multi-omics data is reshaping the global Next Generation Sequencing informatics landscape by fostering a thorough comprehension of biological networks beyond isolated data categories. This movement focuses on merging metabolomic, proteomic, transcriptomic, and genomic information to construct an extensive molecular portrait of a patient, a critical step for classifying treatments and understanding diseases. Consequently, NGS informatics systems are advancing to handle and evaluate these vast, varied datasets, paving the way for more profound biological discoveries. Highlighting the strategic value of combined omics analysis, Illumina, Inc. disclosed its intent to purchase SomaLogic for $350 million in a June 23, 2025, press release titled 'Illumina to acquire SomaLogic, accelerating its proteomics business and advancing the company's multiomics strategy,' aiming to incorporate aptamer-based tools to enhance multiomics biomarker detection.

Another vital trend is the growing incorporation of Next Generation Sequencing informatics into clinical diagnostics, transitioning its use from mostly research-oriented purposes to standard patient healthcare. This shift requires deploying sophisticated analytical programs and software in hospitals and testing labs for tailored treatment strategies, pathogen identification, and genetic disorder screening. Transitioning into these clinical environments necessitates intuitive, reliable informatics systems capable of providing precise and swift data to guide critical medical choices. Emphasizing the substantial medical and financial benefits of this integration, a December 11, 2025, Illumina press release titled 'Illumina and MyOme strike collaboration deal including strategic investment to support MyOme's clinical trial that could save US healthcare $200 billion annually' noted that widespread use of clinical whole-genome sequencing paired with AI-driven risk frameworks could save the system over $200 billion each year.

Key Market Players

• Abbott Laboratories
• F. Hoffmann-La Roche Ltd.
• PerkinElmer, Inc.
• SOPHiA GENETICS SA
• Precigen, Inc.
• QIAGEN N.V.
• Illumina, Inc.
• Agilent Technologies, Inc.
• Eagle Genomics Limited
• BGI Genomics Co., Ltd.

Report Scope

In this report, the Global Next Generation Sequencing (NGS) Informatics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Next Generation Sequencing (NGS) Informatics Market, By Products & Services

• Storage and Computing Tools
• Commercial Data Analysis
• Data Interpretation and Reporting Tools
• Next Generation Sequencing (NGS) Laboratory Information Management Systems (LIMS)

Next Generation Sequencing (NGS) Informatics Market, By Application

• Drug Discovery
• Genetic Screening
• Disease Diagnosis
• Others

Next Generation Sequencing (NGS) Informatics Market, By End User

• Hospitals and Diagnostic Centers
• Pharmaceutical and Biotechnology Companies
• Academic
• Research Institutions

Next Generation Sequencing (NGS) Informatics Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Next Generation Sequencing (NGS) Informatics Market.

Available Customizations:

Global Next Generation Sequencing (NGS) Informatics Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Next Generation Sequencing (NGS) Informatics Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Products & Services (Storage and Computing Tools, Commercial Data Analysis, Data Interpretation, and Reporting Tools, Next Generation Sequencing (NGS) Laboratory Information Management Systems (LIMS))
  • 5.2.2. By Application (Drug Discovery, Genetic Screening, Disease Diagnosis, Others)
  • 5.2.3. By End User (Hospitals and Diagnostic Centers, Pharmaceutical and Biotechnology Companies, Academic, Research Institutions)
  • 5.2.4. By Region
  • 5.2.5. By Company (2025)
• 5.3. Market Map

6. North America Next Generation Sequencing (NGS) Informatics Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Products & Services
  • 6.2.2. By Application
  • 6.2.3. By End User
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Next Generation Sequencing (NGS) Informatics Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Products & Services
      • 6.3.1.2.2. By Application
      • 6.3.1.2.3. By End User
  • 6.3.2. Canada Next Generation Sequencing (NGS) Informatics Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Products & Services
      • 6.3.2.2.2. By Application
      • 6.3.2.2.3. By End User
  • 6.3.3. Mexico Next Generation Sequencing (NGS) Informatics Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Products & Services
      • 6.3.3.2.2. By Application
      • 6.3.3.2.3. By End User

7. Europe Next Generation Sequencing (NGS) Informatics Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Products & Services
  • 7.2.2. By Application
  • 7.2.3. By End User
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Next Generation Sequencing (NGS) Informatics Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Products & Services
      • 7.3.1.2.2. By Application
      • 7.3.1.2.3. By End User
  • 7.3.2. France Next Generation Sequencing (NGS) Informatics Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Products & Services
      • 7.3.2.2.2. By Application
      • 7.3.2.2.3. By End User
  • 7.3.3. United Kingdom Next Generation Sequencing (NGS) Informatics Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Products & Services
      • 7.3.3.2.2. By Application
      • 7.3.3.2.3. By End User
  • 7.3.4. Italy Next Generation Sequencing (NGS) Informatics Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Products & Services
      • 7.3.4.2.2. By Application
      • 7.3.4.2.3. By End User
  • 7.3.5. Spain Next Generation Sequencing (NGS) Informatics Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Products & Services
      • 7.3.5.2.2. By Application
      • 7.3.5.2.3. By End User

8. Asia Pacific Next Generation Sequencing (NGS) Informatics Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Products & Services
  • 8.2.2. By Application
  • 8.2.3. By End User
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Next Generation Sequencing (NGS) Informatics Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Products & Services
      • 8.3.1.2.2. By Application
      • 8.3.1.2.3. By End User
  • 8.3.2. India Next Generation Sequencing (NGS) Informatics Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Products & Services
      • 8.3.2.2.2. By Application
      • 8.3.2.2.3. By End User
  • 8.3.3. Japan Next Generation Sequencing (NGS) Informatics Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Products & Services
      • 8.3.3.2.2. By Application
      • 8.3.3.2.3. By End User
  • 8.3.4. South Korea Next Generation Sequencing (NGS) Informatics Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Products & Services
      • 8.3.4.2.2. By Application
      • 8.3.4.2.3. By End User
  • 8.3.5. Australia Next Generation Sequencing (NGS) Informatics Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Products & Services
      • 8.3.5.2.2. By Application
      • 8.3.5.2.3. By End User

9. Middle East & Africa Next Generation Sequencing (NGS) Informatics Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Products & Services
  • 9.2.2. By Application
  • 9.2.3. By End User
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Next Generation Sequencing (NGS) Informatics Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Products & Services
      • 9.3.1.2.2. By Application
      • 9.3.1.2.3. By End User
  • 9.3.2. UAE Next Generation Sequencing (NGS) Informatics Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Products & Services
      • 9.3.2.2.2. By Application
      • 9.3.2.2.3. By End User
  • 9.3.3. South Africa Next Generation Sequencing (NGS) Informatics Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Products & Services
      • 9.3.3.2.2. By Application
      • 9.3.3.2.3. By End User

10. South America Next Generation Sequencing (NGS) Informatics Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Products & Services
  • 10.2.2. By Application
  • 10.2.3. By End User
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Next Generation Sequencing (NGS) Informatics Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Products & Services
      • 10.3.1.2.2. By Application
      • 10.3.1.2.3. By End User
  • 10.3.2. Colombia Next Generation Sequencing (NGS) Informatics Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Products & Services
      • 10.3.2.2.2. By Application
      • 10.3.2.2.3. By End User
  • 10.3.3. Argentina Next Generation Sequencing (NGS) Informatics Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Products & Services
      • 10.3.3.2.2. By Application
      • 10.3.3.2.3. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Next Generation Sequencing (NGS) Informatics Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Abbott Laboratories
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. F. Hoffmann-La Roche Ltd.
• 15.3. PerkinElmer, Inc.
• 15.4. SOPHiA GENETICS SA
• 15.5. Precigen, Inc.
• 15.6. QIAGEN N.V.
• 15.7. Illumina, Inc.
• 15.8. Agilent Technologies, Inc.
• 15.9. Eagle Genomics Limited
• 15.10. BGI Genomics Co., Ltd.

16. Strategic Recommendations

17. About Us & Disclaimer